Herbas VPB

Print
EN | LT
LT - COMBINATION THERAPY FOR TREATING CANCER WITH A RECOMBINANT POXVIRUS EXPRESSING A TUMOR ANTIGEN AND AN IMMUNE CHECKPOINT MOLECULE ANTAGONIST OR AGONIST
EN - COMBINATION THERAPY FOR TREATING CANCER WITH A RECOMBINANT POXVIRUS EXPRESSING A TUMOR ANTIGEN AND AN IMMUNE CHECKPOINT MOLECULE ANTAGONIST OR AGONIST

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 39/00 (2006.01)
A61K 39/39 (2013.01)
A61K 39/39 (2006.01)
A61K2039/5254 (2013.01)
A61K 39/0011 (2013.01)
A61P 35/00 (2018.01)
A61P 37/04 (2018.01)
A61P 43/00 (2018.01)
A61K 39/001193 (2018.08)
A61K 39/001182 (2018.08)
A61K 39/001194 (2018.08)
A61K 39/00117 (2018.08)
A61K 39/00115 (2018.08)
A61K 39/001106 (2018.08)
European patent
(11) Number of the document 3142690
(13) Kind of document T
(96) European patent application number 15733563.9
Date of filing the European patent application 2015-05-08
(97) Date of publication of the European application 2017-03-22
(45) Date of publication and mention of the grant of the patent 2022-02-23
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2015/029855
Date 2015-05-08
PCT application publication
(87) Number WO 2015/175334
Date 2015-11-19
Priority applications
(30) Number Date Country code
201461992788 P 2014-05-13 US
Inventors
(72)
FOY, Susan , US
MANDL, Stefanie , US
ROUNTREE, Ryan , US
FRANZUSOFF, Alex , US
Grantee
(73) Bavarian Nordic A/S , Hejreskovvej 10A, 3490 Kvistgaard, DK
Title
(54) COMBINATION THERAPY FOR TREATING CANCER WITH A RECOMBINANT POXVIRUS EXPRESSING A TUMOR ANTIGEN AND AN IMMUNE CHECKPOINT MOLECULE ANTAGONIST OR AGONIST
  COMBINATION THERAPY FOR TREATING CANCER WITH A RECOMBINANT POXVIRUS EXPRESSING A TUMOR ANTIGEN AND AN IMMUNE CHECKPOINT MOLECULE ANTAGONIST OR AGONIST